Literature DB >> 9467582

Cytosolic autoantigens in lymphocytic hypophysitis.

P A Crock1.   

Abstract

Lymphocytic hypophysitis was first recognized postmortem, then by biopsy, but detection of antipituitary autoantibodies by immunofluorescence has proved unsatisfactory. Immunoblotting has the dual advantages of increased specificity and identification of the mol wt of autoantigens. Sera from 115 patients and 52 normal subjects were immunoblotted against human autopsy pituitary cytosolic proteins. Among the neurosurgical cohort (30), 10 patients had biopsy-proven lymphocytic hypophysitis, and 20 had hypopituitarism secondary to tumor. There were 22 cases with suspected hypophysitis; 47 with either Hashimoto's, Graves', or Addison's diseases; and 15 with rheumatoid arthritis. Antipituitary autoantibodies reactive to a 49-kDa pituitary cytosolic protein were found in 70% of biopsy-proven lymphocytic hypophysitis, 55% of suspected hypophysitis, 42% of Addison's disease, 20% of pituitary tumors, 15% of patients with thyroid autoimmunity, 13% of rheumatoid arthritis patients, and 9.8% of normal subjects. Reactivity to a 40-kDa cytosolic protein was also found in 50% of patients with biopsy-proven disease. These 49- and 40-kDa autoantigens are conserved across species and are not exclusive to pituitary tissue. Immunoblotting has demonstrated antipituitary autoantibodies to 49- and 40-kDa cytosolic proteins in biopsy-proven cases of lymphocytic hypophysitis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9467582     DOI: 10.1210/jcem.83.2.4563

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  33 in total

1.  Abstracts of the 8th International Pituitary Pathology Meeting. October 5-9, 2001. Greece.

Authors: 
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

Review 2.  Necrotizing infundibuloneurohypophysitis: case report and literature review.

Authors:  Anick Nater; Luis V Syro; Fabio Rotondo; Bernd W Scheithauer; Veronica Abad; Carolina Jaramillo; Kalman Kovacs; Eva Horvath; Michael Cusimano
Journal:  Endocr Pathol       Date:  2012-09       Impact factor: 3.943

3.  Prevalence of antipituitary antibodies in acromegaly.

Authors:  Federica Guaraldi; Patrizio Caturegli; Roberto Salvatori
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

4.  Lymphocytic hypophysitis: late recurrence following successful transsphenoidal surgery.

Authors:  Stylianos Tsagarakis; Dimitra Vassiliadi; Katerina Malagari; George Kontogeorgos; Nicolaos Thalassinos
Journal:  Endocrine       Date:  2004-11       Impact factor: 3.633

5.  Characterization of pituitary cells targeted by antipituitary antibodies in patients with isolated autoimmune diseases without pituitary insufficiency may help to foresee the kind of future hypopituitarism.

Authors:  A De Bellis; A Dello Iacovo; G Bellastella; A Savoia; D Cozzolino; A A Sinisi; A Bizzarro; A Bellastella; D Giugliano
Journal:  Pituitary       Date:  2014-10       Impact factor: 4.107

Review 6.  Pituitary autoimmune disease: nuances in clinical presentation.

Authors:  A Glezer; M D Bronstein
Journal:  Endocrine       Date:  2012-03-17       Impact factor: 3.633

Review 7.  [Hypophysitis : Types and differential diagnosis].

Authors:  W Saeger
Journal:  Pathologe       Date:  2016-05       Impact factor: 1.011

8.  Growth hormone and proopiomelanocortin are targeted by autoantibodies in a patient with biopsy-proven IgG4-related hypophysitis.

Authors:  M A Landek-Salgado; P Leporati; I Lupi; A Geis; P Caturegli
Journal:  Pituitary       Date:  2012-09       Impact factor: 4.107

9.  Intermediate lobe immunoreactivity in a patient with suspected lymphocytic hypophysitis.

Authors:  Casey Jo Anne Smith; Sophie Bensing; Vicki E Maltby; Mingdong Zhang; Rodney J Scott; Roger Smith; Olle Kämpe; Tomas Hökfelt; Patricia A Crock
Journal:  Pituitary       Date:  2014-02       Impact factor: 4.107

10.  Hypophysitis superimposed on a non-functioning pituitary adenoma: diagnostic clinical, endocrine, and radiologic features.

Authors:  N Ballian; A Chrisoulidou; P Nomikos; C Samara; G Kontogeorgos; G A Kaltsas
Journal:  J Endocrinol Invest       Date:  2007-09       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.